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R eply . We appreciate rhe stimulating discussion by de Jong et al. 
to  our recently published article.1 In the study of de Jong,2 in which 
in  vicro-cultured H. pylori strains for the analysis of the CagA status 
were used, the following steps of strain selection may have occurred, 
First, by PCR assay, only the CagA status of single H. pylori colonies 
was tested. However, a high percentage of patients is infected simulta­
neously with two or more strains having different CagA genotypes. 
Second, as discussed by Cover et al,, H. pylori can spontaneously lose 
the CagA gene during in vitro passage.3 Third, the low culture rate 
o f  H, pylori from patients with gastric MALT-type lymphoma (the 
bacterium was successfully cultured in only 12 of 30 patients) may 
additionally contribute to a strain selection. Fourth, further selection 
o f  H. pylori strains may be favored by treatment with chemotherapy 
or radiotherapy, which was performed in the study of de Jong et al,
in  about one third of the patients with MALT-type lymphoma before
2
testing the CagA status.
In contrast to PCR analysis of in vitro cultured strains, serological 
testing permits the detection of an antibody response to all infecting
H. pylori strains regardless of their relative concentration in the stom ­
ach. Therefore, serology is generally thought to be the more accurate 
method for the detection of the CagA status.3,4
One of the two articles cited by de Jong et al, lack controls for validating 
the CagA enzyme-linked immunosorbent assay5 and the other is a review 
article without original data.0 Witherell et al, found a moderately increased 
risk for gastric lymphoma in CagA+-infected individuals and concluded 
chat CagA+ strains may be at higher risk than CagA-  ones.7
Additionally, geographical differences in the prevalence of circulat­
ing H. pylori strains may be responsible for discrepant results of the 
CagA status, a phenomenon already presumed for the lack of correla­
tion of CagA+ strains with peptic ulcer disease and gastric carcinoma 
in some studies.8
We agree with de Jong et al. that a positive serology indicates 
that infection with a CagA-positive strain has occurred in the patient 
during his lifetime and does nor necessarily reflect the present CagA 
status. Studying the mucosal immune response xn the stomach may 
be a better approach for testing the present CagA status. Therefore,
we investigated in a new study the humoral immune response of the 
gastric mucosa by microculture of gastric tissue. In 9 patients tested 
so far, who were ail part of our former study,1 mucosal and serological 
immune response to CagA were identical (8 CagA-positive patients,
1 CagA-negative patient).
Nevertheless, the presence of CagA in a high percentage of patients 
with gastric MALT-type lymphoma is not evidence for a role of CagA 
in the pathogenesis of this disease. However, D'Elios et al.y recently 
found that even at T-cell level, CagA is an immunodominant antigen 
in patients with H, pylon—induced gastritis. They have shown that 
CagA-positive T-cell clones act as potent helper cells for B-cell prolif­
eration. This may represent an important mechanism leading to an 
uncontrolled B-cell proliferation and neoplastic transformation as hy­
pothesized by the authors.9 These data underline that CagA+ strains 
of H. pylori may, together with additional up to now unknown factors, 
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Cost of Endoscopy in Economic 
Evaluation
Dear Sir:
W e read with great interest the study by Heudebert et al.1 in the 
April 1997 issue of G a s t r o e n t e r o l o g y  in which different treat­
ment strategies were compared in patients with severe esophagitis. 
It  was of special interest because we have also carried out an economic 
evaluation to compare different treatment strategies in patients with 
dyspeptic symptoms reported at the 1997 Digestive Week in Wash­
ington. In comparing the results, we noticed the high price ($1105) 
used by Heudebert et al.1 for upper gastrointestinal endoscopy in the
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cosc-utilicy analysis. A review of the literature showed that in eco­
nomic evaluations, the cost for upper gastrointestinal endoscopy varies 
substantially between studies. For example, in the January 1996 issue 
of GASTROENTEROLOGY, Silverstein et a l .2 used a charge of $500 for 
endoscopy, whereas the cost for an upper endoscopy in the study by 
Ofman et al.3 was $555.61.
Because the cost used in economic evaluations may have a major 
influence on the results, uniformity is required. In the studies men­
tioned above, the third-party payer perspective was used implicitly. 
This means that reimbursement charges were used for the analyses. 
However, these charges can deviate from the real cost, which is rele­
vant in the case of a societal perspective,4 In our study, we analyzed 
the real cost for upper gastrointestinal endoscopy at the University 
Hospital Nijmegen in 1993. The real cost for upper gastrointestinal 
endoscopy without hospital overheads was $103, which is only 29% 
of the reimbursement charge ($355).5
W e used the following concept for calculating the real cost,6 which 
can be broken down into three categories: fees, hospital charges, and 
overhead. First, upper gastrointestinal endoscopy normally takes half an 
hour and requires one physician ($43) and one supporting nurse ($10). 
Second, the cost of equipment and materials used, administrative staff, 
and maintenance were calculated on the basis of the total cost of the 
endoscopy department divided by the total number of procedures per­
formed in 1 year; the different types of endoscopy were weighted ac­
cording to time needed to do each one ($50), In another study we have 
recently calculated a figure for hospital overheads, such as housing, en­
ergy, and a general department ($22). This figure was partly based on 
the hospital expenditure per square meter for housing and energy. In 
addition, the cost of personnel at nonmedical departments was used to 
calculate the cost per full-time equivalent employee at the endoscopy 
department. This $22 should be added to the previous categories.
Cost used in economic evaluations should approximate opportunity 
cost. Thus, in general, calculating the real cost or adjusting the figures 
should be considered instead of using the charges as they are.6 There 
will always be differences in the cost of diagnostic or therapeutic 
interventions between countries and even hospitals. Methods used to 
calculate cost should be clearly reported in a standardized way and 
broken down into cost categories (hospital charges, fees, overheads). 
This will make it easier to compare the results of cost analyses and 
provide more information on which to base cost estimates.4
R. J. F. LAHEIJ 
Department of Gastroenterology 
University Hospital Nijmegen
J .  L. SEVERENS
Department o f Medical Informativst Epidemiology, and Statistics 
University of Nijmegen 
The Netherlands
1. Heudebert GR, Marks R, Wilcox M, et al. Choice of long-term strat­
egy for management of patients with severe esophagitis: a cost 
utility analysis. Gastroenterology 1997;112:1078-1086.
2. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empiri­
cal therapy with or without testing for Helicobacter pylori for dys­
pepsia. Gastroenterology 1996;110:72-83.
3. Ofman JJ, Etchanson J, Fullerton S, et al. Management strategies 
for Helicobacter pylori-seropositive patients with dyspepsia: clinical 
and economic consequences. Ann Intern Med 1997;126:280-291.
4. Gold MR, Sirgel JE, Russell LB, et al. Cost-effective ness in health 
and medicine. New York: Oxford University, 1996.
5. Laheij RJF, Severens JL, Jansen JBMJ, et ai. Management in gen­
eral practice of patients with persistent dyspepsia: a decision 
analysis. J Clin Gastroenterol (in press).
6. Canadian Coordinating Office for Health Technology Assessment 
(CC0HTA), A guidance document for the costing process. Ottawa: 
CC0HTA, 1996.
Reply. We read with interest the comments by Laheij and Severens. 
Although we agree with their overall comments, several of their 
statements require clarification and explanation.
W e wish to make clear that our cost-effectiveness analysis was 
explicitly, not implicitly as the authors suggested, modeled from the 
perspective of the third-party payer. In contrast to many European 
countries in which the general population is covered through a N a­
tional Health Care Plan, most individuals in the United States are 
under either traditional indemnity, capitated, or government-spon­
sored (Medicare/Medicaid) coverage. Because patients w ith severe gas­
troesophageal reflux disease are usually in their fourth or fifth decade 
of life (base case analysis considered 45-year-old otherwise healthy 
male), it is very likely that the health care coverage in the United 
States of such individuals would be carried by nongovernment sources. 
As such, we felt the third-party perspective was the most pragmatic 
for generalizability purposes.
Four major issues with the cost estimate for esophagogastroduodenos- 
copy (EGD) used in our model deserve explanation. First, the authors 
of the letter are correct in pointing the cost discrepancies between our 
model and that of Silverstein et al.1 However, applying our institution 
cost per charge ratio of 0.43, the revised figure is approximately US$450, 
much more in accordance to the Silverstein et al. cost estimate of US$500. 
Second, from the third-party perspective, the “true” cost estimate does 
not reflect the actual cost incurred in the management of insured individ­
uals who required an EGD. Third, attempts to reconcile BGD costs 
from Silverstein et al. and our model to the cost estimate presented in 
the letter (US$103) would be irrelevant because their estimate reflects 
salaries and going purchasing prices for supplies at their institution th a t  
are not comparable to true resource use in the United States. Finally, 
and more importantly, EGD was not a sensitive parameter in our model. 
In our sensitivity analysis, we considered an EGD cost as low as US$700, 
which did not alter the results of the analysis; decreasing the cost o f  
EGD further to $400 had similarly negligible effects on the cost estimates 
of both the surgical and medical strategies. Our model, however, was 
sensitive to medication cost, which can only be estimated by using  
published average wholesale prices (i.e., Red Book) or surveying retailers* 
which without a doubt are not reflective of true resource consumption.
The recently convened Panel in Cost-effectiveness Analysis2 has  
recommended using the societal perspective in what they have defined 
the Reference Case and then including revised cost-effectiveness a n d  
marginal cost-effectiveness figures based in the authors’ preferred p e r ­
spective. Although we understand the arguments for such recommen­
dation, we believe that the third-party payer perspective captures t h e  
best audience for our model.
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SECOND INTERNATIONAL CONFERENCE ON 
THERAPIES FOR VIRAL HEPATITIS
Sponsored by International Medical Press, this conference will 
be held December 15-19 , 1997, in Kona, Big Island, Hawaii.
Contact: Dora Moya, International Medical Press, 3112 East 
Shadowlawn Avenue, Atlanta, Georgia 30305; or call (800) 868- 
2022 or (404) 233-2827; or e-mail dora@meditech-media.com.
15TH ANNUAL GASTROENTEROLOGY UPDATE; AN 
INTERDISCIPLINARY AND INTERACTIVE APPROACH
This postgraduate seminar for gastroenterologists, surgeons, oncol­
ogists, radiologists, and internists will focus on recent major advances 
in the diagnosis and treatment of gastrointestinal disease. It is spon­
sored by Johns Hopkins University School of Medicine and Johns 
Hopkins Gallstone and Biliary Disease Center and will be held Febru­
I m a g e  o f  t h e  M o n th  A n s w e r
Answer to Image of the Month Question (page 1822): The EGD image shows mucosal thickening and a polypoid 
mucosal surface. Similar findings were seen in the duodenum and colon., especially the rectum. Mucosal biopsy of the 
gastric antrum (not shown) showed a polypoid mucosal surface with basal cystically dilated glands, varying degrees of 
foveolar hyperplasia, mild nonspecific inflammation, but marked lamina propria edema and expansion, Interpreted in the 
proper clinical context, the histological findings were suggestive of Cronkhite-Canada syndrome (CCS). This led to repeat 
examination of the patient. She had hyperpigmentation of the palms, face, and dorsa of her fingers, as well as variable 
onycholysis and onychodystrophy of all her nails. She also had thin, sparse scalp hair. A diagnosis of Cronkhite-Canada 
syndrome was made.
CCS is a rare, sporadic disorder, with a 3:2 male to female ratio. Although not emphasized in the literature, 75% of 
reported cases are from Japan. Patients with CCS present In later adult life, at a mean age of 60 years. The most common 
gastrointestinal symptoms are nonbloody, protein-losing diarrhea, pain, and weight loss. Patients may have melena or 
hematochezia depending on the degree of erosive lesions. Gastrointestinal polyps are seen in 52%-96% of patients and 
have overlapping histological features with hyperplastic and juvenile retention-type polyps. Basal cystically dilated glands/ 
crypts with marked lamina propria edema and expansion are characteristic. Hyperpigmentation (hypermelanosis) is usually 
diffuse with accentuation over the face, neck, and extremities (85%). Mucous membranes are spared, and there is macular 
pigmentation of the dorsum of hands* Alopecia (95%) is initially patchy with thin, sparse hair resembling alopecia areata, 
but can progress to complete baldness. It usually occurs parallel with onychodystrophy/onycholysis (90%). These cutaneous 
changes often resolve with treatment and may do so spontaneously despite ongoing gastrointestinal disease. Hypoalbumin-' 
emia is common and is accompanied by peripheral edema.
Death is generally caused by malnutrition. Dysplastic change or malignant degeneration is reported and may occur in 
up to 15% of patients. Surgery is harmful and corticosteroids are of little to no benefit. Total parenteral nutrition has led 
to complete resolution, and the current mainstay of therapy for CCS is aggressive nutritional support. Our patient was 
treated with protein infusions, followed by maintenance on a high-protein diet and Imodium (2 mg orally four times 
daily). The patient’s gastrointestinal symptoms, hypoaibuminemia, and edema have all resolved.
For submission instructions, please fax the Editorial Office at (301) 951-0757, or write to: Editorial Office, 7910
W oodmont Avenue, 7th Floor, Bethesda, Maryland 02814-3015*
ary 1-6, 1998, at Manor Vail Lodge in Vail, Colorado, offering 19 
AM A Category 1 credit hours.
Contact: Conference Coordinator at Johns Hopkins Medical Insti­
tutions, Office of CME, Turner 20/720 Rutland Avenue, Baltimore,
Maryland 21205-2195; or call (410) 955-2959; or fax (410) 955-
0807; or e-mail cmenet@som.adm.jhu.edu.
UPDATE IN HEPATOLOGY AND LIVER 
TRANSPLANTATION 1998
This meeting will be held at the Caribe Royale Resort, Lake Buena 
Vista, Florida, on March 19-21, 1998. The course is designed to 
provide a comprehensive update of recent advances in the evaluation 
and management of patients with viral hepatitis, cholestatic and meta­
bolic liver disease, hepatic malignancies, and liver transplantation. 
Conracr; CME Office, Mayo Clinic Jacksonville; or call (800) 462-
9633 or (904) 953-7114.
